Although there are nearly 150,000 prostate cancer survivors treated in the VA healthcare system, there has been little research to understand and improve survivorship care for this population. A substantial proportion of prostate cancer survivors have significant side effects from their surgery or radiation therapy, and these side effects contribute to decreased quality of life. This is particularly unfortunate since many of these symptoms can be effectively self-managed.
To address the need to improve patient-centered survivorship care, CMCD affiliated investigator, Sarah Hawley, PhD and other are conducting a randomized controlled trial of prostate cancer survivors at three VA sites. The primary goal of the trial is to compare a personally-tailored automated telephone symptom management intervention to usual care. The study will provide much needed information about how to optimize the quality of care and quality of life for men who are survivors of prostate cancer.
For more information, contact Tabitha Metreger at email@example.com.